A phase II study of CI-973 [SP-4-3(R)]- [1, 1-cyclobutane-dicarboxylato (2-)] (2-methyl-1,4-butanediamine-N, N′) platinum in patients with refractory advanced breast cancer

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Cancer Chemotherapy and Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s002800050484PMID 8646805
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Carboplatin activity in untreated metastatic breast cancer patients — results of a phase II study

  2004cited by this paper
• Carboplatin: an active drug in metastatic breast cancer.

  1992cited by this paper
• Phase I and pharmacokinetic study of the novel platinum analogue CI-973 on a 5-daily dose schedule.

  1992cited by this paper
• A Phase II Trial of Iproplatin (CHIP) in Previously Treated Advanced Breast Cancer

  1989cited by this paper
• Clinical trial of iproplatin (cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV, CHIP) in patients with advanced breast cancer

  1988cited by this paper
• Phase II study of iproplatin in metastatic breast carcinoma.

  1987cited by this paper
• Assessment of response to therapy in advanced breast cancer.

  1977cited by this paper
• Prediction of Creatinine Clearance from Serum Creatinine

  1976cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper
• Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide

  1960cited by this paper

• What blocks more anticancer platinum complexes from experiment to clinic: Major problems and potential strategies from drug design perspectives

  2021cites this paper
• Platinum-Based Compounds for the Treatment of Metastatic Breast Cancer

  2012cites this paper
• The status of platinum anticancer drugs in the clinic and in clinical trials.

  2010cites this paper
• In vitro histoculture drug response assay and in vivo blood chemistry of a novel Pt(IV) compound, K104.

  2007cites this paper
• Studies on new trinuclear palladium compounds

  2007cites this paper
• Preclinical and clinical studies on the use of platinum complexes for breast cancer treatment.

  2007cites this paper
• The development of platinum compounds and their possible combination.

  2006cites this paper
• Oxaliplatin-related neurotoxicity: how and why?

  2006cites this paper
• Platinum compounds in the treatment of advanced breast cancer.

  2001cites this paper
• Platinum neurotoxicity: clinical profiles, experimental models and neuroprotective approaches.

  1999cites this paper
• Review of recent trials of chemotherapy for advanced breast cancer: studies excluding taxanes.

  1997cites this paper